European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF): Poster Presentation Abstracts

Corradini, C.; Maione, Alessio; Crapanzano, Calogero; Ferrara, Francesco; Stuflesser, W.; Verdoia, C.

doi:10.1007/s00198-013-2312-y

Cited by 5 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The method seems to be very promising. Preliminary results showed that US diagnosis coincided with the corresponding DXA ones for 86.1% of spines and for 81.0% of femurs [77][78][79][80][81][82][83][84][85][86][87][88][89] .…”

Section: New Advances In Us Diagnosis Of Osteoporosismentioning

confidence: 95%

Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques

Pisani¹

2013

WJR

153

View full text Add to dashboard Cite

Effective prevention and management of osteoporosis would require suitable methods for population screenings and early diagnosis. Current clinically-available diagnostic methods are mainly based on the use of either X-rays or ultrasound (US). All X-ray based methods provide a measure of bone mineral density (BMD), but it has been demonstrated that other structural aspects of the bone are important in determining fracture risk, such as mechanical features and elastic properties, which cannot be assessed using densitometric techniques. Among the most commonly used techniques, dual X-ray absorptiometry (DXA) is considered the current "gold standard" for osteoporosis diagnosis and fracture risk prediction. Unfortunately, as other X-ray based techniques, DXA has specific limitations (e.g., use of ionizing radiation, large size of the equipment, high costs, limited availability) that hinder its application for population screenings and primary care diagnosis. This has resulted in an increasing interest in developing reliable pre-screening tools for osteoporosis such as quantitative ultrasound (QUS) scanners, which do not involve ionizing radiation exposure and represent a cheaper solution exploiting portable and widely available devices. Furthermore, the usefulness of QUS techniques in fracture risk prediction has been proven and, with the last developments, they are also becoming a more and more reliable approach for assessing bone quality. However, the US assessment of osteoporosis is currently used only as a pre-screening tool, requiring a subsequent diagnosis confirmation by means of a DXA evaluation. Here we illustrate the state of art in the early diagnosis of this "silent disease" and show up recent advances for its prevention and improved management through early diagnosis.

show abstract

Section: New Advances In Us Diagnosis Of Osteoporosismentioning

confidence: 95%

Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques

Pisani¹

2013

WJR

153

View full text Add to dashboard Cite

show abstract

“…A study on 51 Caucasian women with AI also showed TBS impairment in comparison with normal TBS values for age, while no differences were found for BMD. Hypogonadism and hypercortisolism presented a negative effect on TBS but not on BMD [41]. Another study concerning the risk factors for fracture in endogenous Cushing's syndrome (CS) patients revealed that the only predictor of low traumatic fracture, after adjustment for age, gender, BMD, and TBS was the level of free cortisol in 24-hour urine sample.…”

Section: Glucocorticoids and Tbsmentioning

confidence: 99%

Trabecular bone score (TBS) as a noninvasive and complementary tool for clinical diagnosis of bone structure in endocrine disorders

Halupczok-Żyła

Bolanowski

2019

Endokrynologia Polska

View full text Add to dashboard Cite

Trabecular bone score (TBS) index has recently been obtained as a result of textural greyscale analysis of DXA images. Because it enables the assessment of bone microarchitectural texture, TBS may be useful in evaluating bone quality. This study explores the current knowledge of the use of TBS in patients with endocrine disorders with co-occurring bone structure changes. Currently, the clinical importance TBS was verified in terms of disorders of the growth hormone/insulin-like growth factor 1 (GH/IGF-I) axis, glucocorticoid excess, thyroid and parathyroid disease, as well as in diabetes mellitus type 1 and 2. It has been clarified that patients suffering from various endocrinopathies are a group in which TBS should be used routinely because it correlates with clinical factors and may improve patient management in various endocrine disorders. (Endokrynol Pol 2019; 70 (4): 350-356)

show abstract

Tobacco Use by Arab Women

Dar‐Odeh¹,

Abu‐Hammad²

2021

Handbook of Healthcare in the Arab World

View full text Add to dashboard Cite

European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF): Poster Presentation Abstracts

Cited by 5 publications

References 0 publications

Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques

Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques

Trabecular bone score (TBS) as a noninvasive and complementary tool for clinical diagnosis of bone structure in endocrine disorders

Tobacco Use by Arab Women

Contact Info

Product

Resources

About